Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 9,675,900 | 9,835,600 | 10,173,400 | 10,981,700 | 13,444,600 |
| Cost of Goods | 2,310,400 | 2,533,400 | 2,278,300 | 2,109,700 | 1,805,200 |
| Gross Profit | 7,365,500 | 7,302,200 | 7,895,101 | 8,872,000 | 11,639,400 |
| Operating Expenses | 5,116,300 | 5,690,300 | 4,411,800 | 6,032,000 | 6,592,101 |
| Operating Income | 2,249,601 | 1,612,300 | 3,483,601 | 2,840,700 | 5,047,499 |
| Other Income | -343,601 | -315,500 | 110,799 | -1,060,600 | 5,301 |
| Pre-tax Income | 1,906,000 | 1,296,800 | 3,594,400 | 1,780,100 | 5,052,800 |
| Income Tax | 273,800 | 135,300 | 632,800 | 52,500 | 992,300 |
| Net Income Continuous | 1,632,200 | 1,161,500 | 2,961,600 | 1,727,600 | 4,060,500 |
| Minority Interests | N/A | 400 | -85,300 | 171,500 | 59,900 |
| Net Income | $1,632,200 | $1,161,100 | $3,046,900 | $1,556,100 | $4,000,600 |
| EPS Basic Total Ops | 11.21 | 8.02 | 20.96 | 10.44 | 24.86 |
| EPS Basic Continuous Ops | 11.21 | 8.03 | 20.38 | 11.59 | 25.24 |
| EPS Diluted Total Ops | 11.18 | 7.97 | 20.87 | 10.40 | 24.80 |
| EPS Diluted Continuous Ops | 11.19 | 7.98 | 20.28 | 11.55 | 25.17 |
| EPS Diluted Before Non-Recurring Items | 16.47 | 14.72 | 17.67 | 19.22 | 33.70 |
| EBITDA(a) | $3,213,000 | $2,138,600 | $4,121,601 | $3,957,700 | $5,504,699 |